Transchem (500422.BO) Stock Price

Transchem Price

CLOSED
414.60
​
Market closed

Revenue at Transchem has contracted by 16.9% per year over the past 18 years to 26.30 M INR. Earnings per share have grown at 7.3% per year over the last 19 years. Transchem's net margin stands at 198.7%, up from 1.5% several years earlier.

Transchem stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem business model & stock analysis

Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector.

Frequently asked questions about Transchem

Converted at the current exchange rate, the Transchem share trades at 3.89 EUR (414.60 INR).

The revenue cannot currently be calculated for Transchem.

The profit of Transchem is 42.95 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Transchem is currently 118.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Transchem stock.

The P/S cannot be calculated for Transchem currently.

The Eulerpool Quality Score for Transchem is 1/10.

The ISIN of Transchem is INE019B01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Transchem is 500422.BO. The ticker symbol is used to trade Transchem shares on the stock exchange.

Fair ValueTerminal
377.29 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jan 27, 1993
ISIN
INE019B01010
Cusip
Y8968G118
Market capitalization
5.07 B INRMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
6.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.14 %
Last updated Oct 19, 2026, 4:32 AM

Transchem Peer Group

Transchem FIGI

TCH:IN · BBG000D19422TCH:IB · BBG000D195D7